Rishi Puri, M.D., PhD
Cleveland Clinic Main Campus
Cleveland,
OH
USA
Biographical Sketch: Rishi Puri is a coronary and structural interventional cardiologist at the Cleveland Clinic. Rishi has published over 450 manuscripts across a broad topic base including transcatheter structural heart interventions for valvular heart disease and heart failure, atherosclerosis progression-regression and plaque imaging, and coronary physiology/pharmacology. He is actively involved in developing novel device-based technologies in the coronary, structural heart disease and interventional heart failure spaces, has co-founded and advises a range of medical start-up companies and larger strategics. He currently serves as global co-PI for the TRICAV-1 and TRICAV-2 FDA pivotal trial testing a bi-caval stenting system for patients with severe TR, the ADVANCE-DCB FIM trial of a dual API nanoparticle drug-eluting balloon in de novo coronary lesions, is the US national co-PI for the ALLAY-HFrEF trial. He also serves on the global steering committees of a range of other pivotal trials in the aortic and mitral valve therapy space
Papers: